MICROBIAL LIBERATION OF N-METHYLSEROTONIN FROM ORANGE FIBER CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority from U.S. Provisional Application Serial No. 63/331,038 filed on 14 April 2022, which is incorporated herein by reference in its entirety. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH & DEVELOPMENT [0002] This invention was made with government support under grant number DK070977 awarded by the National Institutes of Health. The government has certain rights in the invention. SEQUENCE LISTING [0003] This application contains a sequence listing in computer readable format, the teachings and content of which are hereby incorporated by reference. FIELD OF THE DISCLOSURE [0004] The field of the disclosure relates generally to mining bioactive compounds (e.g., N-methylserotonin) from natural fiber sources using specialized gut microbes, as well as therapeutic prebiotic, probiotic, or synbiotic compositions and methods thereof. BACKGROUND OF THE DISCLOSURE [0005] Identifying the products of metabolism of dietary components by members of human gut communities and determining how these products mediate microbe-microbe and microbe-host interactions holds the promise of generating new approaches for modulating host functions in ways that improve health status. Dietary fibers exemplify this point. Fibers are chemically complex; they include but are not limited to structurally diverse polysaccharide components, proteins and lipids. The association between increased consumption of dietary fiber and improved health status is widely recognized. Some of the underlying mediators and mechanisms are well known. For example, short-chain fatty acids produced by microbial metabolism of otherwise indigestible plant polysaccharides have been linked to beneficial health outcomes. The gut microbiota affects the bioavailability of (poly)phenolic compounds contained in dietary fiber by metabolizing them to smaller bioactive products. In addition to these observations about fiber, there is a rapidly expanding knowledge base of how the products of microbial community metabolism and microbial-host co-metabolism affect human biology in healthy and disease states. [0006] Population growth, the existential threat posed by climate change, and associated challenges to environmental sustainability have focused attention on the design of eco-friendly food systems; this includes management of the massive amount of inorganic as well as organic `waste' generated during the food manufacture. Fibers are well represented in many of these manufacturing streams; for example, in the peels, rinds and seeds discarded from different fruits and vegetables. The composition of the fibers present in these byproduct streams reflect their differing sources as well as the various mechanical, physical and chemical steps applied during food processing. [0007] Fibers from these manufacturing streams represent a potentially enormous biorepository of unknown or largely uncharacterized natural molecular entities having health promoting effects. Moreover, the biochemical versatility of microbes present in the human gut microbiota provide a resource for liberating these compounds. For example, N-methylserotonin is a tryptamine alkaloid found in commercial food-grade preparations of orange fiber that are generated as a byproduct (waste stream) of the juice making process. However, N- methylserotonin is physically entrapped within orange fiber. Consequently, it cannot be easily extracted (such as with water, methanol, acetonitrile) and is thus not ‘bioavailable’ in its native form. [0008] Accordingly, there is a need for compositions and methods for effectively liberating bioactive compounds from fibers for significant host physiological and metabolic benefit. BRIEF DESCRIPTION OF THE DISCLOSURE [0009] The present disclosure illustrates embodiments for harnessing microbial mining capacity to identify chemical entities naturally contained within fibers emanating from manufacturing streams, defining their effects on host physiology, characterizing the mechanisms underlying microbial mining, and translating preclinical model results to humans. More specifically, the present disclosure describes prebiotic (orange fiber alone) compositions and synbiotic (orange fiber plus a specific gut microbial strain capable of mining N-methylserotonin from orange fiber, e.g. B. ovatus TSDC17.2-1.1) compositions. When combined, the orange fiber plus the specific gut microbial strain unexpectedly liberates pharmacologically active levels of N-methylserotonin from the fiber into the gut of a human being or animal. This novel discovery has a number of therapeutic applications, including but not limited to irritable bowel syndrome treatment and potentially aspects of metabolic health/glucose homeostasis. Administration of the synbiotic enables the benefits of orange fiber-derived N-methylserotonin to be realized in subjects whose microbiomes otherwise lack the requisite expressed enzymes for mining this compound from orange fiber. [0010] Gnotobiotic mice colonized with defined consortia of cultured human gut bacterial strains were previously used to characterize the effects of adding 34 different dietary fiber preparations to a diet high in saturated fats and low in fruits and vegetables (abbreviated HiSF- LoFV). This diet was formulated based on the NHANES database of diet consumption patterns by humans living in the USA; `high' and `low' were defined as levels in the upper and lower tertiles of the diets captured in this database. These mice were used to characterize mechanisms by which members compete or cooperate in utilizing specific glycan structures present in these fiber preparations. Germ-free mice plus gnotobiotic mice are herein used and colonized with defined consortia of human gut bacterial taxa that were fed this HiSF-LoFV diet with or without an orange fiber byproduct of juice manufacture. The results revealed microbe-dependent release of N-methylserotonin from the fiber preparation. The effects of N-methylserotonin on host metabolism, and gene expression in the intestine and liver, were characterized by adding this compound to drinking water consumed by germ-free animals. Mechanisms underlying N- methylserotonin release were delineated in vitro, initially with 49 phylogenetically diverse human gut bacterial strains, and then by performing functional genomic analysis under different media conditions using 12 different strains of Bacteroides ovatus, a prominent miner in vivo. Finding that B. ovatus mining activity was regulated by addition or subtraction of a single component (hemin or ferric chloride heme, which is an iron-containing porphyrin) from one of the media tested led to the unexpected discovery that strain-specific expression of genes involved in metabolism of pectic glycans in the fiber preparation correlated with liberation of N- methylserotonin. In a test of a translatability to humans, orange fiber- and control pea fiber- containing snack food prototypes were administered to adult female dizygotic twins in two open- label, single group assignment studies. Levels of N-methylserotonin in feces exhibited a dose- dependent relationship with changes in the representation of bacterial genes encoding glycoside hydrolases and polysaccharide lyases that break down pectic glycans. This approach is generally useful for identifying components of fibers whose liberation under normal physiological conditions requires microbial assistance, yet whose biological/pharmacological activities are not dependent on further microbial biotransformation. [0011] In one aspect, the present disclosure is directed to a synbiotic composition comprising at least one type of plant fiber and at least one microbial strain. In some embodiments, the at least one type of plant fiber comprises a Rutaceae family plant fiber, the Rutaceae family plant fiber comprises citrus fiber, the citrus fiber comprises orange fiber, the at least one microbial strain comprises at least one bacterial strain, the at least one bacterial strain is selected from Bacteroides, Parabacteroides, Collinsella, and combinations thereof, the at least one bacterial strain comprises at least one strain of Bacteroides ovatus, Bacteroides finegoldii, Parabacteroides distasonis, Collinsella aerofaciens, and combinations thereof, the at least one bacterial strain comprises Bacteroides ovatus TSDC 17.2, further comprising an iron-containing porphyrin, and/or the iron-containing porphyrin is hemin. [0012] In another aspect, the present disclosure is directed to a method for locally delivering a bioactive compound to a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a synbiotic composition comprising at least one type of plant fiber and at least one microbial strain. In some embodiments, the at least one microbial strain is a source of at least one CAZyme, the at least one CAZyme is selected from PL9, GH5_37, GH5_8, GH59, GH30_5, GH26, GH5_4, GH25, GH13_31, GH123, GH13_19, GH13_28, and combinations thereof, the at least one CAZyme comprises PL9, and/or the bioactive compound is N-methylserotonin. [0013] In yet another aspect, the present disclosure is directed to a method for increasing liver glycogen, increasing tissue glutamate levels, reducing adiposity, reducing high fat diet induced obesity, increasing fatty acid metabolism, decreasing gastrointestinal transit time, colonic motility, and/or treating irritable bowel syndrome in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a synbiotic composition comprising at least one type of plant fiber and at least one microbial strain. [0014] In yet another aspect, the present disclosure is directed to a prebiotic composition comprising an iron-containing porphyrin and at least one type of plant fiber. In some embodiments, the iron-containing porphyrin is hemin, the at least one type of plant fiber comprises a Rutaceae family plant fiber, the Rutaceae family plant fiber comprises citrus fiber, and/or the citrus fiber comprises orange fiber. [0015] In yet another aspect, the present disclosure is directed to a method for locally delivering a bioactive compound to a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a prebiotic composition comprising an iron-containing porphyrin and at least one type of plant fiber. In some embodiments, the bioactive compound is N-methylserotonin. [0016] In yet another aspect, the present disclosure is directed to a probiotic composition comprising an iron-containing porphyrin and at least one microbial strain. In some embodiments, the iron-containing porphyrin is hemin, the at least one microbial strain comprises at least one bacterial strain, the at least one bacterial strain is selected from Bacteroides, Parabacteroides, Collinsella, and combinations thereof, the at least one bacterial strain comprises at least one strain of Bacteroides ovatus, Bacteroides finegoldii, Parabacteroides distasonis, Collinsella aerofaciens, and combinations thereof, and/or the at least one bacterial strain comprises Bacteroides ovatus TSDC 17.2. [0017] In yet another aspect, the present disclosure is directed to a method for locally delivering a bioactive compound to a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a probiotic composition comprising an iron-containing porphyrin and at least one microbial strain. In some embodiments, the at least one microbial strain is a source of at least one CAZyme, the at least one CAZyme is selected from PL9, GH5_37, GH5_8, GH59, GH30_5, GH26, GH5_4, GH25, GH13_31, GH123, GH13_19, GH13_28, and combinations thereof, the at least one CAZyme comprises PL9, and/or the bioactive compound is N-methylserotonin. BRIEF DESCRIPTION OF THE DRAWINGS [0018] The embodiments described herein may be better understood by referring to the following description in conjunction with the accompanying drawings. [0019] FIG. 1(A-C) is an exemplary embodiment of colonization and orange fiber- dependent accumulation of N-methylserotonin in the intestines of gnotobiotic mice in accordance with the present disclosure. FIG.1A shows cecal contents harvested from germ-free or colonized mice fed either an unsupplemented high saturated fat/low fruits and vegetable (HiSF-LoFV) diet or the HiSF-LoFV diet supplemented with 10% orange fiber, were analyzed by LC-Qtof-MS. The analyte with an m/z of 191.1180 was only found in colonized animals consuming the orange fiber supplemented diet. Chromatograms representative of five biological replicates for each treatment group are shown. FIG. 1B shows collision-induced dissociation mass spectra of an N- methylserotonin standard (upper portion of panel) and cecal extracts (lower portion of panel) obtained by LC-Qtof-MS/MS. FIG. 1C shows levels of N-methylserotonin released after a 72h incubation of each of 14 bacterial strains with orange fiber in TYG medium. Mean values ± SD per 50 mg of orange fiber are shown. See also Table S1, Table S2, and Table S4. [0020] FIG. 2(A-H) is an exemplary embodiment of effects of orally administered N- methylserotonin in germ-free mice in accordance with the present disclosure. FIG. 2A shows experimental design. Groups of adult germ-free mice consumed the HiSF-LoFV diet ad libitum. Animals received one of two doses (1 mg/kg/day and 50 mg/kg/day) of N-methylserotonin in their drinking water for 21 days. FIG. 2B shows percent change in body weight between experimental days 1 and 21. FIG.2C shows epidydimal fat pad weight at the time of euthanasia. FIG.2D, 2E, 2F, and 2G show metabolites related to glycogen biosynthesis measured in the liver at euthanasia. FIG. 2H shows transit time through the gastrointestinal tract of germ-free mice measured on day 17 (4-5 mice/treatment group). Mean values ± SD are shown in panels B-H. Filled circles indicate values for individual animals. *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001 (one-way ANOVA). Colors used to denote treatment groups in panels B-H are keyed to the colors employed in panel A. Each dot represents results from a single animal. See also FIG. 6 and Table S3. [0021] FIG. 3(A-G) is an exemplary embodiment of specificity and host physiologic effects of N-methylserotonin release from the orange fiber-supplemented HiSF-LoFV diet by human gut bacterial strains in vivo in accordance with the present disclosure. FIG. 3A shows experimental design. FIG.3B shows composition of 14-, 10- and 4-member bacterial consortia used to colonize mice. FIG. 3C shows absolute abundances of organisms comprising each consortium as defined by shotgun sequencing of DNA isolated from fecal samples collected on experimental day 21. FIG.3D shows N-methylserotonin levels in feces obtained on experimental day 21. FIG.3E shows percent change in body weight between experimental days 1 and 21. FIG. 3F shows epididymal fat pad weight expressed as a percentage of body weight. FIG.3G shows gastrointestinal transit time. Mean ± SD values are shown in panels C-G. *, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001 (one-way ANOVA). Colors used in panels C-G denote treatment groups and are keyed to match the colors employed in FIG.3B. See also Table S5. [0022] FIG.4(A-C) is an exemplary embodiment of in vitro B. ovatus strain-specific N- methylserotonin ‘mining’ phenotypes and identification of candidate genes involved in its release from orange fiber in accordance with the present disclosure. FIG.4A and FIG.4B show in vitro release of N-methylserotonin after a 72h incubation of each of 12 bacterial strains with orange fiber in TYG medium containing hemin (FIG. 4A) or lacking hemin (FIG.4B). Mean values ± SD per 50 mg orange fiber for triplicate incubations are shown. FIG.4C shows selection criteria for identifying genes designated as candidate members of the N-methylserotonin mining apparatus of B. ovatus TSDC 17.2 based on their patterns of expression in mining permissive and non-permissive in vitro conditions. All comparisons made are between incubations with or without orange fiber (OF) for 72h using the indicated culture media and B. ovatus strains (TSDC 17.2 or 115). The log <sub>2</sub> fold differences in expression of the nine genes listed, in the presence or absence of OF in TYG medium containing hemin, are statistically significant (FDR corrected p<0.05; Benjamin and Hochberg). For other conditions: " " denotes p>0.05 while "N/A" indicates the absence of an ortholog in the genome of strain 115. See also FIG. 7, Table S4, Table S6 and Table S7. [0023] FIG.5(A-B) is an exemplary embodiment of dose-dependent and fiber-dependent accumulation of N-methylserotonin of adult dizygotic twin pairs consuming fiber snack food prototypes in accordance with the present disclosure. FIG. 5A shows LC-QqQ-MS based measurements of fecal N-methylserotonin levels in members of twin pairs consuming the indicated fiber snack prototypes as a function of the number of snacks consumed per day. Each dot represents data for a single participant. Mean values ± SD are shown. **, p<0.001; Friedman's test with Dunn's multiple comparison. FIG.5B shows Spearman correlation analysis performed between the abundances of all CAZyme genes and levels of N-methylserotonin in fecal samples collected from participants at the end of week 1 (unrestricted diet, no fiber snacks) and at the end of week 5 (unrestricted diet supplemented with 3 orange fiber snacks /day). The heatmap and bar plot display loge-fold changes in the abundances of GH and PL genes and levels of N- methylserotonin. Shown are 12 CAZymes whose abundances in the microbiome were significantly correlated with levels of N-methylserotonin at weeks 1 and 5. Each column in the heatmap and each bar in the bar graph represent the response of an individual study participant. Hierarchical clustering (Euclidean distances) was used to group participants and CAZymes with similar responses to consumption of orange fiber snacks. Participant code: TPO1.01 = twin pairl, co-twin 1. The circles on the right side of the heat map indicate the FDR-corrected statistical significance of the Spearman rho correlation; q < 0.1, * q < 0.05, ** q < 0.01. n=22 participants, n=44 fecal samples analyzed. See also Table S8. [0024] FIG. 6 is an exemplary embodiment of over-representation analysis of GO Biological Process terms in the set of genes differentially expressed in the livers of germ-free mice in response to orally administered N-methylserotonin in accordance with the present disclosure. Related to FIG. 2(A-H) and Table S3. GO terms are ranked by gene ratio with a p- value cutoff of 0.05. [0025] FIG.7 is an exemplary embodiment of HTCS_Rgu-2 regulon analysis in three B. ovatus strains in accordance with the present disclosure. Related to FIG. 4(A-C) and Table S7. Predicted HTCS Rgu-2 binding sites (PUL number and the ID of their component genes are based on B. ovatus TSDC 17.2 and described in Table S7). Predicted members of the HTCS Rgu-2 regulon are indicated by the solid line on top. Sequence logo shows the consensus for identified HTCS Rgu-2 binding sites. DETAILED DESCRIPTION OF THE DISCLOSURE [0026] Plant fibers in byproduct streams produced by non-harsh food processing methods represent biorepositories of diverse naturally-occurring physiologically-active biomolecules. To demonstrate one approach for their characterization, mass-spectrometry of intestinal contents from gnotobiotic mice, plus in vitro studies, revealed liberation of N-methylserotonin from orange fibers by human gut microbiota members including Bacteroides ovatus. Functional genomic analyses of B. ovatus strains grown under permissive and non-permissive N-methylserotonin `mining' conditions revealed members of polysaccharide utilization loci that target pectins whose expression correlate with strain-specific liberation of this compound. N-methylserotonin, orally- administered to germfree mice, reduced adiposity, altered liver glycogenesis, shortened gut transit time, and changed expression of genes that regulate circadian rhythm in liver and colon. In human studies, dose-dependent, orange fiber-specific fecal accumulation of N-methylserotonin positively correlated with levels of microbiome genes encoding enzymes that digest pectic glycans. Identifying this type of microbial mining activity has potential therapeutic implications. [0027] According to the present disclosure, when orange fiber preparations are exposed to specific human gut bacteria (in vitro and in vivo), the actions of specific enzymes encoded by this select group of microbes are able to release the entrapped N-methylserotonin from the orange fiber matrix. This produces a soluble/free from of N-methylserotonin that is bioavailable (without further microbial biotransformation) at pharmacologically relevant levels - demonstrated both in the mouse gut, and in the feces of participants in a human study of diet supplementation with orange fiber snacks. [0028] Using a germ free mouse model, we have shown that administration of N- methylserotonin in the drinking water, at concentrations comparable to those ingested by supplementing the diet with an orange fiber preparation, produces beneficial effects on host metabolism and gene expression in the intestine and liver, plus a significant reduction in gut transit time with potential therapeutic implications (e.g. an approach for treatment of certain forms of irritable bowel syndrome). [0029] The present disclosure describes species and strain-level specificity of human gut bacteria that are able to release (‘mine’) N-methylserotonin from orange fiber. Among the cultured, sequenced bacterial strains tested in vitro, several were able to mine N-methylserotonin from orange fiber at low levels, however few possessed strong releasing/mining activity: Bacteroides ovatus TSDC17.2-1.1, Parabacteroides distasonis TSDC17.2-1.1, Collinsella aerofaciens TSDC17.2-1.1, and Bacteroides finegoldii TSDC17.2-1.1. A consortium of those 4 strains, when introduced into germ free mice fed an orange fiber supplemented diet, was able to release N-methylserotonin from the orange fiber into the gut luminal contents of recipient mice. RNA-Seq analysis of gene expression in a 'strong' versus 'weak' Bacteroides ovatus 'mining' strain incubated in the presence or absence of orange fiber in vitro, revealed a set of glycoside hydrolase and polysaccharide lyase genes whose expression were associated with release of N- methylserotonin. [0030] Moreover, the known/predicted substrate specificities of the encoded enzymes were consistent with the prominent representation of pectic polysaccharides present in orange fiber, suggesting that cleavage of these polysaccharides is a prerequisite for release of N- methylserotonin. Further, a study of a small cohort of adult female dizygotic twins who supplemented their normal diets with an escalating dose of a snack food prototype containing orange fiber over a period of 5 weeks disclosed a dose-dependent, orange-fiber specific accumulation of N-methylserotonin in their feces. The orange fiber preparation and its releasable N-methylserotonin are thus be viewed as a natural analog of oral polysaccharide-based drug delivery systems. [0031] EXPERIMENTAL MODEL [0032] Gnotobiotic mice. Experiments involving gnotobiotic mice were performed using protocols approved by Washington University Animal Studies Committee. Ten-week-old male germ-free C57BL/6J animals were housed in plastic flexible film gnotobiotic isolators (Class Biologically Clean) at 23 °C under a strict 12-hour light cycle (lights on a 0600h, off at 1800h). [0033] Germ-free animals were weaned onto an autoclaved, low-fat, plant polysaccharide-rich chow (catalog number 2018S, Envigo) administered ad libitum. Four days prior to colonization, mice were switched to a diet formulation containing ingredients that in aggregate represented the upper tertile of saturated fat consumption and the lower tertile of fruits and vegetable consumption of USA diets as reported in the National Health and Nutrition Examination Survey (NHANES) database. Pelleted unsupplemented HiSF-LoFV diet and the diets supplemented with 10% (w/w) orange fiber (CitriFi 100; Fiber Star) or 10% (w/w) pea fiber (EF 100; Rettenmaiers) were vacuumed packed in plastic bags and subsequently sterilized by gamma irradiation (20-50 kilograys, Steris, Mentor, OH). Sterility was confirmed by culturing the material under aerobic and anaerobic (atmosphere, 75% N2, 20% CO2, 5% H2) conditions at 37 °C in TYG medium. [0034] The bacterial strains used to colonize mice had been cultured from a fecal sample obtained from a lean co-twin in an obesity-discordant twin pair (TSDC 17). Equivalent numbers of bacterial cells (based on OD600 measurements) in monocultures (grown in TYG medium under anaerobic conditions to stationary-phase) were pooled to create gavage mixtures. A total of 200 µL of each pool, consisting of all 14 strains, the four strains identified as capable of releasing N- methylserotonin from orange fiber in vitro (B. ovatus, P. distasonis, C. aerofaciens, B. finegoldii), or a mixture of the other 10 strains, were introduced into mice using a plastic-tipped oral gavage needle (Fisher). [0035] Animals were maintained in separate gnotobiotic isolators each dedicated to mice colonized with the same bacterial consortium (n=5 animals/cage). Cages contained autoclaved paper `shepherd shacks' to facilitate their natural nesting behaviors and to provide environmental enrichment. Pre-colonization fecal samples were collected to verify the germ-free status of the mice using both culture and culture-independent assays. [0036] For experiments involving administration of N-methylserotonin to germ-free mice, a stock solution of the compound (100 mg/mL, Santa Cruz Biotechnologies) was prepared in sterile water and filter sterilized (0.2 gm pore size; Nalgene). The outer surface of tubes containing the stock solution was sterilized with Clidox (Pharmacal) and the tubes were introduced into gnotobiotic isolators using standard procedures. The stock solution was then diluted in darkened glass water bottles (Ancare) in order to administer doses of 1 mg/kg/day or 50 mg/kg/day (based on an experimentally determined average consumption of 5 mL of water/day/mouse). Every four days, bottles were replaced with new ones containing fresh N- methylserotonin. Each of the three arms of the experiment, including the control arm where unsupplemented drinking water was administered, consisted of 5 mice. However, in case of the higher dose treatment group, one animal died within the first week without any preceding behavioral changes or signs of illness, or decipherable underlying cause. [0037] Fecal samples and body weights were collected weekly, while food and water intake were monitored daily by comparing pellet mass in the food hopper and the volume of water in water bottles at the beginning and end of a 24h period and dividing these values by the number of mice per cage. All animals were euthanized between 0830h and 0930h without prior fasting. Luminal contents from the proximal and distal halves of the small intestine, the cecum and the colon, host tissues (liver, epididymal fat pads, gastrocnemius muscle, the distal quarter of the small intestine (ileum), cecum and entire colon) plus serum were collected, flash frozen in liquid nitrogen and stored at -80 °C prior to analyses. [0038] Human studies with pea and orange fiber snack prototypes. Two separate open-label, single group assignment studies were performed involving members of the Missouri Adolescent Female Twin Study (MOAFTS) cohort who were age 31-45 years at the time of enrollment. The first study with the pea fiber snack was performed between April and August 2017, while the second study with the orange fiber snack was conducted between August and December 2017. All participants provided written informed consent and the studies were approved by the Washington University Institutional Review Board (IRB ID#201611122). (ClinicalTrials.gov NCT03078283). [0039] The design of the two studies were identical except for the fiber snack supplement used and the number of participants in each study. Individuals who were pregnant or trying to get pregnant, had inflammatory bowel disease, gastrointestinal cancer, hepatitis, HIV, renal failure, or allergies to dairy, eggs, fish, crustacean shellfish, tree nuts, sesame seeds, peanuts, wheat, gluten, soybeans, celery, or mustard were excluded from the study. In Study 1, four twin pairs were concordant for obesity (BMI >30 kg/m2) while five pairs were discordant with one member being obese and the other non-obese (n=18 participants, 36.6±2.9 years (mean ± SD); Table S8B). Study 2 involved 24 participants: 12 dizygotic twin pairs [37±2.9 years (mean ± SD)], nine of whom had participated in the pea fiber study; for these nine pairs, the interval between cessation of pea fiber snack consumption and initiation of orange fiber consumption ranged from 50 to 106 days [84+26 days (mean + SD)]. Participants consumed their normal, unrestricted diet for the first two weeks of the study (pre-intervention phase). At the beginning of week three, they supplemented their diets with one 35g fiber snack serving a day for one week, then two 35g snack servings a day the following week, and thereafter, three 35g snacks per day for four weeks (weeks 5-8) at breakfast, lunch and dinner. No attempt was made to adjust the diets of participants other than supplementation with the fiber snack. Snack prototypes were manufactured by Mondeldz International, Inc. (see Table S8A for their composition), which participants received in weekly shipments from the study center. The pea fiber snacks were in the form of rotary biscuits (6.7g total fiber/35g snack) or extruded bars (8.1g fiber/35g snack) with participants having the option to alternate between them. The orange fiber snacks were all in the form of extruded bars (10.2g total fiber/35g snack). Compliance was monitored throughout by the study coordinator through weekly phone calls. The primary outcomes for each study were the effects of the respective prototypes on gut microbial community structure and function. [0040] Fecal samples were collected by participants in small medically approved collection containers. Each fecal sample was frozen immediately at -20 °C and temporarily stored in dedicated freezers provided to participants at the beginning of the study. Within 12-48 hours after collection, all samples were shipped, via overnight delivery, in an insulated container containing frozen gel packs, to a biospecimen repository located in Washington University in St. Louis and overseen by one of the authors (A.C.H.). Once received, samples were stored at -80°C until processing for LC-QqQ-MS analysis of N-methylserotonin levels and culture-independent characterization of ASV and CAZyme gene abundances. [0041] Measurement of fecal N-methylserotonin levels - Each fecal sample was homogenized with a porcelain mortar (4 L) and pestle while submerged in liquid nitrogen; multiple 500 mg aliquots of the pulverized frozen material were stored at -80 °C. N- methylserotonin was quantified using the same protocol that was employed for mouse fecal samples (as described herein elsewhere). [0042] Shotgun sequencing of fecal DNA and quantification of CAZyme gene abundances - DNA was purified from fecal samples that had been collected at the t=1 week and 5-week time points from study participants. Sequencing libraries were generated from each purified fecal DNA sample and sequenced [Illumina NextSeq 550 and HiSeq 3000 instruments; 10.7 ±0.6 x 10 ⁶ (mean ± SD) and 6.9 ± 1.1 x 10 ⁶ (mean ± SD) 150 nt paired-end reads/sample). Host-filtered reads were assembled and annotated using prokka (Seemann, 2014) and counts for each open reading frame (ORF) were generated by mapping paired-end reads from each sample to its assembled DNA contigs. Alignments were processed to generate count data (featureCounts; Subread v.1.5.3 package) for each ORF in each sample and normalized (TPM). [0043] ORFs identified in each fecal sample were used as the starting point for CAZyme annotation. Aggregating abundance data for each sample enabled the generation of CAZyme gene family/subfamily abundance tables. (The abundances of GH and PL genes annotated with multiple CAZyme families/ subfamilies were propagated to each individual family/subfamily member, and abundances were then summed across all corresponding CAZyme families within each fecal sample). [0044] 16S rDNA amplicon sequencing and identification of ASVs - PCR was performed using purified fecal DNA and barcoded primers directed against variable region 4 of the bacterial 16S rRNA gene. PCR amplification was performed as described in a previous publication; amplicons with sample-specific barcodes were quantified, pooled and sequenced (Illumina MiSeq instrument, paired-end 250 nucleotide reads). Paired-end reads were demultiplexed, trimmed to 200 nucleotides, merged, and chimeras were removed (version 1.13.0 of the DADA2 pipeline). Amplicon sequence variants (ASVs) were aligned against GreenGenes 2016 (v.13.8) to 97% sequence identity, followed by taxonomic and species assignment [RDP 16 (release 11.5) and SILVA (v.128)]. The resulting ASV table was filtered to only include those ASVs with >0.1% relative abundance in at least five fecal samples, and then rarefied to 15,000 reads/sample. [0045] METHODS [0046] Measurement of gastrointestinal transit times using non-absorbable red carmine dye. This protocol was adapted from a previously method. Carmine red (Sigma-Aldrich) was prepared as a 6% (w/v) solution in 0.5% methylcellulose (Sigma-Aldrich) and autoclaved prior to import into isolator. Seventeen days after initiation of N-methylserotonin treatment, 200 µL of the carmine red solution were gavaged into each germ-free mouse between 0800 and 0815h. Feces were collected every 15 minutes and streaked across a sterile white napkin to assay for the presence of the carmine red dye. The time from oral gavage to initial appearance of carmine red in the feces was recorded as the total intestinal transit time for that animal. [0047] Absolute abundances of community members. Short-read community profiling by sequencing (COPRO-Seq) was used to define the absolute abundances of bacterial taxa in fecal samples from colonized mice. For absolute abundance determination, 22.1x10 ⁶ million Agrobacterium radiobacter DSM 30147 cells and 6.6x10 ⁶ Alicyclobacillus acidiphilus DSM 14558 cells were added to each frozen fecal pellet. DNA was isolated from the pellets by adding 500µL of extraction buffer [200mM Tris (pH 8), 200 mM NaCl, 20 mM EDTA], 210 mL of 20% SDS, and 500 mL of 0.1 mm diameter zirconia beads, followed by treatment with a BioSpec bead beater for 4 minutes, addition of 500µL phenol:chloroform:isoamyl alcohol (25:24:1), and precipitation of nucleic acids with isopropanol. Libraries were prepared using the Nextera DNA Library Prep Kit (Illumina) and combinations of custom barcoded primers. Multiplex sequencing of the libraries was performed using an Illumina Hi-Seq instrument (paired end 75 nucleotide reads; 2.65 x 10 ⁶ ± 1.5 x 10 ⁵ reads/sample). Reads were mapped onto the sequenced genomes of consortium members using an analytic pipeline described in previous publication. Absolute abundances, expressed as genome equivalents per gram of material, was calculated for each community member by multiplying the normalized counts of that member with the abundances of the spike-in (number of cells per normalized count) and dividing by the measured weight of the fecal sample. [0048] RNA-Seq of liver and colonic tissue. Frozen tissue was broken into small pieces and ground into a very fine powder under liquid nitrogen using a mortar and pestle. A 25 mg aliquot of powdered tissue was then aliquoted into shearing matrix F (MP Bio) pre-chilled in liquid nitrogen; 0.5 mL of buffer LBP (Takara) was added immediately and the mixture was placed on a 4 °C cold block. Samples were then disrupted (Biospec bead beater; 2 minutes). The remaining steps in the RNA isolation procedure were performed using a Takara Nucleospin RNA Plus kit. After verifying that all purified RNAs had an RNA integrity number (RIN) greater than 8.5 (Agilent RNA Pico), a 1 Ong aliquot of each sample was used to generate a cDNA library (Illumina TruSeq Stranded Total RNA). Libraries were sequenced using an Illumina Hi-Seq instrument (paired end 75 nucleotide reads; 1.43 x 10 ⁷ ± 3.74 x 10 ⁶ reads/liver sample, and 3.27 x 10 ⁷ ± 1.23 x 10 ⁶ reads/colon sample). Reads were aligned to the Mus musculus GRCm39 genome assembly with STAR version 2.7.0d. Gene count data were generated from the number of uniquely aligned reads (featureCounts Subread version 1.6.2a). The R package DESEQ2 was used to perform differential gene expression analysis; results were filtered based on an adjusted Benjamini and Hochberg FDR p-value <0.05. Gene set enrichment analysis was carried out using ClusterProfiler with an adjusted p-value cut-off of <0.05 and minimum gene-set size of 3; over- representation was carried out using a loge fold-change cut-off of >1. [0049] In vitro screening of bacterial strains for N-methylserotonin releasing activity. A given bacterial strain was grown in monoculture at 37 °C in TYG medium in an anaerobic chamber (atmosphere; 75% N2, 20% CO2 and 5% H2) to stationary phase. An aliquot was then added to 10 mL of fresh TYG medium with or without 50 mg of orange fiber that had been sterilized by gamma irradiation (30-50 KGy); the mixture was incubated under anaerobic conditions without shaking for 72 hours. A 200 µL aliquot was then removed for targeted LC- QqQ-MS measurement of N-methylserotonin levels; another aliquot was used to define the number of colony-forming units so that levels of the analyte were expressed per 10 ⁶ cells. An identical protocol was used to compare the amount of N-methylserotonin released when two other rich media, MEGA medium 2.0 and Wilkins-Chalgren anaerobe broth (Thermo-Fisher), were used in lieu of TYG. All incubations were performed in triplicate for each condition. [0050] Experiments to determine whether N-methylserotonin is synthesized de novo by B. ovatus were carried out in 10 mL TYG with or without supplementation with tryptophan, tryptamine, serotonin, dimethylserotonin, trimethylserotonin, methyltryptamine, or S-adenosyl methionine (final concentrations; 5 mg/mL; all from Sigma). Experiments seeking to test the capacity of all 14 bacterial strains introduced into mice to degrade N-methylserotonin in vitro were carried out using 10 mL TYG and 50 ng N-methylserotonin, with samples collected every 24 hours. Assays were performed in triplicate for each condition, using the protocol described herein. [0051] Experiments seeking to test the necessity of having live bacteria to extract N- methylserotonin were carried out by first incubating monocultures of B. ovatus, B. finegoldii, P. distasonis and C. aerofaciens in 10 mL TYG medium at 37 °C under anaerobic conditions to stationary phase. The stationary phase culture was then treated at 70 °C for 1 hour. Cells were recovered by centrifugation (6,000 x g for 15 minutes at 4 °C) and the pellet was added to 10 mL of TYG medium containing 5mg/mL of orange fiber. [0052] Experiments using conditioned media were carried out by taking monocultures of B. ovatus, B. finegoldii, P. distasonis, and C. aerofaciens that had been grown to stationary phase in TYG under anaerobic conditions, centrifuging the culture for 15 minutes at 6,000 x g at 4 °C to remove bacterial cells and adding 10 mL of the conditioned medium to 50 mg orange fiber. [0053] Experiments using bacterial lysates were carried out by bead-beating of bacterial cells, collected by centrifugation from 10 mL stationary phase TYG cultures for 4 minutes at room temperature; 500 µL of the resulting lysate was added to 10 mL of a solution containing 5 mg orange fiber/ mL TYG medium. To ensure sterility in these experiments, aliquots of the heat- treated cells, centrifuged conditioned media, or bacterial lysate were cultured in TYG medium for 7 days and subsequently plated on TYG-agar; the results confirmed the absence of colony forming units. Assays were performed in triplicate for each experimental condition. [0054] For screening the 24 additional non- B. ovatus strains, 3 mg of orange fiber was seeded into a deep 96-well plate; a liquid handling robot (Precision XS, Biotek) added 0.6 mL of Wilkins-Chalgren anaerobe broth to each well (yielding a final concentration of 5 mg orange fiber/mL). Each well was subsequently inoculated with 50 µL of a stationary phase culture of the bacterial strain targeted for screening and sealed with foil. The screen was performed in triplicate and carried out under identical conditions as the 14-strain experiment. [0055] Genomic DNA extraction and purification. Bacterial isolates were inoculated into TYG media and were grown at 37°C in an anaerobic chamber with an atmosphere of 75% N2, 20% CO2 and 5% H2 until reaching stationary phase. A 10 µL aliquot was transferred into 10 mL of fresh TYG media and was incubated for 72 hours under anaerobic conditions without shaking. A fraction of the broth was removed for full-length 16S sequencing to confirm the identity of culture isolates, and the remaining growth was spun down at 3,000G for 5 minutes, yielding a 10-50 mg cell pellet, which was transferred to a 2 mL cryo-tube for DNA extraction. A 3.97 mm steel ball and 250 µL of 0.1 mm zirconia/silica beads were added to the tube along with a 500 µL mixture of 25:24:1 parts phenol:chloroform:isoamyl alcohol (pH 7.8-8.2), 210 µL of 20% SDS, and 500 µL of 2X buffer A (200 mM NaCl, 200 mM Trizma base, 20 mM EDTA). Samples were bead-beat for 1 minute in a Biospec Minibeadbeater-96 and were then centrifuged at 3220g for 4 minutes. Following centrifugation, 420 µL of aqueous phase was transferred to a deep 96-well plate for subsequent DNA isolation. DNA was isolated using a QlAquick 96-well PCR purification kit with liquid handling performed using a Biomek FX robot. DNA was eluted from the column in 70 µLTris-EDTA (TE) buffer and was quantified with a Quant-iT dsDNA broad range kit. [0056] Long-read library preparation and sequencing. Approximately 1 ug of genomic DNA from each isolate was transferred into a 96-well, 0.8 mL, deep-well plate and was prepared for long-read sequencing using a SMRTbell Express Template Prep Kit 2.0 from Pacific Biosciences (PacBio) as described by the manufacture's guidelines for preparing HiFi Libraries from low DNA input, with adaptations for 96-well plate format. Purified DNA was of appropriate quality (DIN range: 6.8-7.9) and size (range of median peak size: 14.1-23.8 kb) for HiFi library preparation; therefore, no DNA shearing or size selection was performed prior to template preparation. All DNA handling and transfer steps were performed with ART wide-bore, genomic DNA pipette tips. Initial steps were performed as described in the PacBio protocol, including removal of single stranded overhands, DNA damage repair, end repair, and A-tailing. Barcoded adapters were ligated to A-tailed DNA fragments by overnight incubation at 20C and were then treated with the SMRTbell Enzyme Cleanup Kit to remove damaged or partial SMRTbell templates. Ligated templates were purified, and size selected with 0.45x AMPure PB beads (45:100, AMPure beads:sample), and the size-selected libraries were pooled to yield equal genome coverage (3-6 libraries/pool). A second round of size selection with 0.45x AMPure PB beads was performed after pooling, and DNA was eluted in 12 µL of PacBio elution buffer. [0057] Pooled libraries were quantified by Qubit, and the size distribution was evaluated on an Agilent TapeStation using Genomic DNA ScreenTape. The median fragment size for the 4 library pools ranged from 14.5 kb to 16.9 kb. Each library was sequenced on a Sequel System from Pacific Biosciences using a Sequel Binding Kit 3.0 and Sequencing Primer v4 with 24 hours of data collection. [0058] Genome assembly and annotation. Samples were demultiplexed and Q20 circular consensus sequencing (CCS) reads were generated using a Cromwell workflow configured in SMRT Link. Genomes were assembled using Flye v2.8.1 with hifi-error set to 0.003, min-overlap set at 2000, and other options set to default. Genome quality was evaluated using checkm and annotated using the RASTtk pipeline. [0059] Microbial RNA-Seq. Samples were prepared for microbial RNA-seq as described herein, except under the following conditions: a) Bacteroides ovatus TSDC 17.2 was grown in TYG, TYG without hemin, and MEGA media (b) Bacteroides ovatus 115, TYG was grown with or without 5 mg/ml orange fiber under quadruplicate conditions (n =4). A volume of 10 mL of 72-hour growth was centrifuged to yield 10-50 mg of pelleted bacteria, which was extracted by phenol chloroform as described herein. [0060] A 3.97 mm steel ball and 250 µL of 0.1 mm zirconia/silica beads were added to each sample tube along with a 500 µL mixture of 25:24:1 parts phenol:chloroform:isoamyl alcohol (pH 7.8-8.2), 210 µL of 20% SDS, and 500 uL of 2X buffer A (200 mM NaCl, 200 mM Trizma base, 20 mM EDTA). Samples were then bead-beat for 1 minute in a Biospec Minibeadbeater-96 and were centrifuged at 3220g for 4 minutes. A 100 µL fraction of the aqueous phase was transferred to a deep 96-well plate along with 70 µL isopropanol and 10 µL 3M NaOAc, pH5.5 and was mixed by pipetting 10-times. The crude DNA/RNA mixture was chilled at -20 °C for approximately 1 hour and then centrifuging at 3220 x g at 4 °C for 15 minutes before removing 210 µL of the supernatant to yield nucleotide-rich pellets. A Biomek FX robot was used to add 300 µL Qiagen Buffer RLT to the pellets and resuspend the RNA/DNA by pipetting up and down 50-times. A 400 µL volume was transferred to an AllPrep 96 DNA plate and was centrifuged at 3220 RCF for 1 min at room temperature. The RNA flow-through was purified as described in the AllPrep 96 protocol; DNA was then eluted from the column and retained. [0061] Libraries were prepared from extracted RNA using the Illumina Stranded Total RNA Prep Ligation with Ribo-Zero Plus and were sequenced on an Illumina Next-Seq instrument using single end 75-nucleotide reads (1.33 x 10 ⁷ ± 1.06 x 10 ⁶ reads/microbial sample). Reads were aligned to assembled genomes using bowtie. The resulting counts table was passed onto the R package DESEQ2 for differential gene expression analysis, where results were filtered as described. Sequence-based comparisons between genes expressed and/or present in B. ovatus strain TSDC 17.2 with B. ovatus strain 115, as well as the other B. ovatus strains were subsequently carried out on the SEED system, where a bidirectional BLAST search was carried out setting B. ovatus strain TSDC 17.2 as the reference genome for comparison. Annotation of PULs and regulon analysis were carried out as described. [0062] Sample extraction for mass spectrometric analyses. All samples were maintained on liquid nitrogen throughout the extraction process. Frozen tissue was broken into small pieces and ground into a fine powder using a mortar and pestle. The powder was aliquoted into open-capped tubes (Reinforced, Thermo) pre-chilled in liquid nitrogen. Each sample was added to a 20 times weight volume of methanol along with 3-5 stainless steel beads (2.8mm, Biospec) in a reinforced tube (Benchmark Scientific, catalog number D1031-RF) and placed on a pre-chilled block (20 °C). For gut contents, feces and in vitro screening samples, tubes were shaken using a Biospec bead beater for 4 minutes. For host tissues, tubes were shaken using a Biospec bead beater for two cycles of 4 minutes each, switching to a new chilled block each time that the bead beater was activated. For each plasma sample, a 40 µL aliquot was added to 4 mL of extraction solution (40% methanol in water) followed by addition of 20 µL of 100 nM tricarboxylic acid. After a 10-minute incubation at room temperature, samples were briefly vortexed and then centrifuged at 12,000 x g for 10 minutes at 4 °C; 200 µL of the resulting supernatant was transferred to a 2 mL glass tube (Agilent) and dried in a speed vacuum at room temperature for two hours. The dry extract was reconstituted in 100 µL of 90% water/10% acetonitrile and stored at -4 °C prior to injection into a mass spectrometer. [0063] Untargeted LC-Qtof-MS. Untargeted metabolomics was performed using an Agilent 1290 LC system coupled to an Agilent Model 6545 Qtof mass spectrometer (Santa Clara, CA). Five µL of each sample extract for positive ESI ionization was injected onto a BEH C18 column (2.1 x 150 mm, 1.7 µm, Waters Corp., Milford, MA) that was heated to 35 °C. The mobile phase consisted of 0.1% formic in water (A) and 0.1% formic acid in acetonitrile (B). A flow rate of 0.3 mL/minute was applied (gradient program: from 0 to 14 minutes, mobile phase B eluted from 5% to 100%, followed by 3 minutes at 100% of B). An equilibration time of 3 minutes was used. Data were collected in positive ESI ionization modes in the range from m/z 50 to 1000, and m/z 150 to 650 for MS full-scan analysis and MS/MS analysis, respectively. The key parameters of Qtof were set as the following: nozzle voltage, 1000 V; capillary voltage, 3000 V; drying gas, N2; drying gas flow rate, 10.0 L/min; collision gas, high purity N2; drying gas (N2) temperature, 325°C; vaporizer/sheath gas temperature, 350 °C; sheath gas flow rate, 12 L/min. To ensure accurate mass measurements, reference masses m/z 121.0509 and 922.0098 were automatically delivered using a dual ESI source during analyses. The mass accuracy of the LC-MS system used herein was generally better than 4 ppm. Samples were randomly analyzed. [0064] The resulting raw data sets were deconvoluted using MassHunter Profinder B.08.00 software (Agilent Technologies, Santa Clara, CA) which generated a list of molecular features. These features were subsequently filtered using in-house scripts in order to identify those that were only present in all samples obtained from mice that were colonized and fed the orange fiber supplemented HiSF-LoFV diet. Initial characterization of the resulting subset of features was performed by monoisotopic mass search in METLIN (metlin.scripps.edu) and HMDB (hmdb.ca). These features were fragmented by targeted MS/MS with collision energy from 0 to 40 V. Final metabolite identification was performed by co-characterization with standards. [0065] Targeted LC-QqQ-MS. N-methylserotonin - Five microliters of sample extract were injected into a 1290 Infinity II UHPLC system coupled to a Model 6470 Triple Quadrupole LC/MS system equipped with a Jet Stream electrospray ionization source (Agilent Technologies). Chromatographic separation was performed on a ZORBAX Extend-C18, 2.1 x 50 mm, 1.8 µm column (Agilent Technologies) and the following gradient conditions: 5-95% solvent B (methanol/0.1% formic acid); 0-3 minutes at a flow rate of 0.2 mL/minute. Mass spectra were acquired in positive mode and quantification transitions for N-methylserotonin at 191—>160. [0066] Other metabolites - Tissue (at least 10 mg) was placed in a reinforced 2 mL tube. A 20 times weight volume of extraction solvent was added (40% acetonitrile, 40% methanol, 20% water) and the tissue was disrupted as described herein. Samples were centrifuged at 12,000 x g for 10 minutes at 4 °C. A 200 µL aliquot of the resulting supernatant was transferred to a 2 mL glass tube and dried in a speed vacuum at room temperature (25 °C) for two hours. The dry extract was reconstituted in 100 µL of 90% water/10% acetonitrile and stored at -4 °C prior to injection; 5µL was injected into a 1290 Infmity II UHPLC system coupled to a 6470 Triple Quadrupole LC/MS system equipped with a Jet Stream electrospray ionization source (Agilent Technologies). Chromatographic separation was performed on an Agilent ZORBAX Extend C18, 2.1 x 150 m, 1.8 µm column, using the following gradient conditions: mobile phase A, 10mM tributylamine and 15mM acetic acid in 3% methanol (v/v); mobile phase B, 10mM tributylamine and 15mM acetic acid in 100% methanol; 0% solvent B (0-2 minutes); 0-20% solvent B (2-7.5 minutes); 20- 45% solvent B (7.5-13 minutes); 45-99% solvent B (13-20 minutes); 99-0% solvent B (20-22 minutes) at a flow rate of 0.25 mL/minute. Mass spectra were acquired in negative mode using the following conditions: capillary voltage set at 2000V; nitrogen as the nebulizer gas (45 psi); drying gas flow rate and temperature of 13 L/minute and 250 °C, respectively; sheath gas flow rate and temperature of 12 L/minute and 325 °C. Transitions were taken from the Agilent Metabolomics dMRM Database. [0067] Quantification and statistical analysis. Details regarding statistical tests used, replicates and representation of means and standard deviations are provided herein throughout in the specification text, figure legends, and tables. [0068] Data and code availability. Annotated B. ovatus genomes, microbial RNA-seq, and COPRO-Seq, liver and colonic RNA-Seq datasets from gnotobiotic mice have been deposited at the European Nucleotide Archive (ENA; ebi.ac.uk/ena) under accession number PRJEB40461. Metabolomics data are available in the EMBL-EBI MetaboLights database (identifier MTBLS2331). Shotgun and 16S rDNA amplicon sequencing datasets generated from human fecal DNAs are available in ENA (study accession PRJEB44020). [0069] Enzymatic screening of citrus & plant samples. All enzymatic assays are carried out using a total volume of 10ml in water, 50 mg of plant fiber material tested and 700 active units of the same cellulase enzyme mixture (Sigma) as described herein. Samples were processed based on their condition, divided as follows. Citrus fibers sourced from various citrus types, described in Table S9 as “Ground,” are added directly to the enzymatic assay, while citrus fibers described as either “Granule” or “Whole” are first manually pulverized into a fine powder via mortar and pestle. The commercially available fiber source is classified as “Ground” if it was already processed into fine powder, or otherwise small enough granules in which individual pieces cannot be manually picked up via forceps. The commercially available fiber source is classified as “Granule” or “Whole” if individual fragments or pieces of the fiber is readily discernable, where “Granule” are applied to visibly uniform samples and “Whole” applied to all other samples. Assays were performed in triplicate for each sample type tested after an incubation of 72 hours. The extraction and subsequent detection of N- methylserotonin is described herein elsewhere. [0070] Enzymatic assays were carried out in identical fashion as Table S9, differing only in the preparation of the materials tested (see Table S10). For the locally sourced citrus experiments, the peel, pulp, and fruit of the various citruses were separated into their respective portions, then chopped and ground to a fine powder/paste where then 250 mg of this raw material are applied to the enzymatic digestion assay with or without enzyme (as noted in Table S10 where appropriate). Samples designated “Skin” refer to solely the epicarp/flavedo, inedible, hardened portion of the peel that are visually distinctive by color. Samples designated “Pulp” refer to the mesocarp/albedo, the inner layer of the skin, as well as endocarp membranes which overlaps with the edible portion of the fruit. Samples designated “Fruit (with pulp)” refer to the edible portion of the citrus fruit, or segments of the endocarp containing the juice vesicles, which also includes the membranous endocarp layer. For liquid samples (designated “Juice”), 50µL juice, squeezed from the locally sourced citrus fruits or else taken directly from the commercially available source are either first passed through a 0.22 µm filter syringe or else directly applied to the enzymatic digestion assay process via identical methods described in Table S9. [0071] Enzymatic assays were carried out in identical fashion as Table S9, differing only in the preparation of the materials tested (see Table S11(A-E)). In case of dried materials such as grains or various herbs, the samples are ground to a fine powder via mortar and pestle. In case of wet materials such as various raw fruits and vegetables, the samples are instead chopped to a fine paste-like consistency where no visual distinction could be made of individual components.1g of each processed material (dried weight or wet weight) is then applied to the enzymatic digestion assay as described in Table S9. Sample types marked “Fiber” or “Pre-Ground” indicate that the samples come from a commercially prepared source, where some degree of mechanical or culinary application has been carried out.50mg of this type of material is applied to the enzymatic assay as described in Table S9 with no additional processing prior to extraction. [0072] STAR METHODS KEY RESOURCE TABLE [0073] Table 1A. Strains

[0074] Table 1B. Reagents and Resources

[0075] RESULTS [0076] A gnotobiotic mouse model reveals human gut bacterial liberation of N- methylserotonin from orange fiber. As a starting point for characterizing liberation of fiber- associated bioactive constituents by gut bacterial taxa, a commercial, food-grade source of orange fiber was selected (see Methods), derived from the byproducts of the juicing process; these byproducts include pulp cells, juice vesicles, segment membranes, rag/core and peel that are mechanically processed (washed with water, heated, dewatered, sheared) prior to drying. Importantly for the purpose of experiments for the present disclosure, the preparation had not been subject to chemical treatment or extraction; therefore, any proteins, lipids, and small molecules that are not removed by washing with water are retained in the preparation (see Table S1A,B for composition and glycosidic linkage analysis of constituent polysaccharides). [0077] Two groups of adult C57BL/6J germ-free mice were colonized with a 14-member consortium of sequenced human gut bacterial strains and monotonously fed the HiSF-LoFV diet ad libitum, with or without supplementation with 10% (w/w) orange fiber, for 21 days. Two other groups of mice were maintained as germ-free; mice in one of these groups were fed the unsupplemented HiSF-LoFV diet while those in the other group consumed the 10% orange fiber- supplemented diet (n=5 animals/treatment group). [0078] Untargeted liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-Qtof-MS) of cecal contents harvested at the time of euthanasia revealed 116 features (m/z) that were increased at least 3-fold in colonized mice consuming the orange fiber-supplemented diet compared to the other three experimental groups (Table S2). A prominent feature with an m/z of 191.1186 was present at high abundance only in colonized mice fed the orange fiber- supplemented diet (FIG. 1A); it was tentatively identified as methylserotonin, with its major fragment (m/z 160.0760) consistent with methylation of its alkyl amine. Subsequent LC- Qtof/MS/MS co-characterization with a known standard confirmed that this compound was N- methylserotonin (FIG. 1B). N-methylserotonin has been previously identified in several plants, including black cohosh, Japanese pepper, and citrus fruits. There is very limited information on whether this compound has beneficial or potentially detrimental physiologic effects. [0079] The experiment was repeated and further compared different groups of mice colonized with the 14-member consortium and fed the HiSF-LoFV diet supplemented with 10% orange fiber or with 10% pea fiber. The latter was a natural food-grade commercial preparation consisting of insoluble and soluble fibers as well as resistant starch ( e Methods and Table S1A for composition). Targeted liquid chromatography-triple quadrupole mass spectrometry (LC- QqQ-MS) revealed that N-methylserotonin was present in significantly higher amounts in both the cecal and colonic contents and tissues of mice consuming the orange fiber-supplemented diet [173 ± 14 ng/g and 130 ± 13 ng/g (mean ± SD) in cecal contents and cecal tissue, respectively and 139 ± 13 ng/g and 164 ± 25 ng/g in colonic contents and tissue, respectively] compared to their small intestine, liver, gastrocnemius muscle and kidney (<1 ng/g) or plasma (1.22 ± 0.76 ng/mL). Non-targeted LC-Qtof-MS and targeted LC-QqQ-MS analysis revealed no statistically significant differences (p>0.05; t-test) in the levels of serotonin, dimethylserotonin, trimethylserotonin, 5-hydroxyindoleacetic acid, tryptamine, N-methyltryptamine, N,N- dimethyltryptamine, tryptophan, bufotenin or melatonin in small intestinal, cecal and colonic tissue or liver obtained from animals consuming the unsupplemented versus orange fiber- supplemented HiSF-LoFV diet, indicating that the host is unable to metabolize N-methylserotonin to these products. N-methylserotonin was below the limits of detection (<0.5 ng/g) in cecal or colonic contents or any of these intestinal and extra-intestinal tissues harvested from mice consuming the pea-fiber supplemented diet. [0080] Host effects of N-methylserotonin. To characterize the effects of N- methylserotonin on host physiology and metabolism, 12-week-old germ-free C57BL/6J mice were fed the unsupplemented HiSF-LoFV diet and administered N-methylserotonin via their drinking water at doses of 1 mg/kg/day or 50 mg/kg/day for 21 days (FIG. 2A). The 1 mg/kg/day dose was experimentally determined to result in fecal N-methylserotonin levels that were equivalent to those documented in mice colonized with the 14-member community consuming the orange fiber-supplemented HiSF-LoFV diet (133.5 ± 15 ng/g versus 131 ± 19 ng/g feces, respectively; p=0.92, unpaired t-test). The 50 mg/kg/d dose was equivalent to the estimated total amount of N-methylserotonin consumed each day in the 10% orange fiber-containing diet (based on the yield obtained after in vitro enzymatic digestion of the fiber with T. reesei cellulase). A control group of germ-free animals did not receive any N-methylserotonin. Food and water intake were measured daily and remained consistent throughout the experiment among all three groups of mice. [0081] While a statistically significant decrease in weight gain was observed with N- methylserotonin treatment (FIG. 2B), interpreting this result is confounded by the abnormally large contribution of the cecum to body weight in germ-free mice. However, compared to untreated controls, oral administration of N-methylserotonin resulted in a statistically significant reduction in epididymal fat mass at the higher dose but not the lower dose (FIG. 2C). [0082] The higher dose also produced statistically significant increases in liver glycogen (FIG. 2D) and statistically significant decreases in its metabolic precursors, uridine and uridine monophosphate (FIG. 2E,F), which the lower dose did not. Administration of the higher dose resulted a statistically significant decrease in liver glucose-6-phosphate (FIG. 2G), a key metabolic intermediate formed from either glycogenolysis or gluconeogenesis that is known to directly impact levels of glycogen in the liver, while the lower dose did not. Based on these results, untreated control animals and those that received 50 mg/kg/d of N-methylserotonin were used to perform RNA-Seq on liver and colon. [0083] A total of 716 genes exhibited statistically significant differences in their expression in the livers of N-methylserotonin-treated compared to untreated mice (FDR adjusted p-value <0.05; see Methods and Table S3A,B). Gene-set enrichment analysis and over- representation analysis (Methods) of all statistically significant differentially expressed genes (FDR adjusted p-value <0.05) revealed that GO Biological Pathway terms pertaining to circadian rhythm and fatty acid metabolism were the most significantly enriched (FIG. 6). Effects of N- methylserotonin on circadian rhythm-related genes included significantly decreased expression of Arntl and Clock [see Table S3 for loge-fold change and FDR adjusted p-values], both of which have been linked to suppressed gluconeogenesis and lipogenesis. Consistent with this observation, there were significant increases in expression of their regulators Per2, Per3, and Nr1d2. Per2 promotes glycogen synthesis. Moreover, genetically engineered disruption of Per3 is associated with resistance to leptin with resulting weight gain, while its deletion directly leads to increased adipogenesis. Nr1d2 acts a repressor of Nfil3; its statistically significant increased expression with N-methylserotonin treatment is associated with statistically significantly decreased hepatic levels of Nfil3 mRNA. Nfil3 serves as an important link between the gut microbiota, intestinal epithelial lipid metabolism and body composition. Nfil3 expression exhibits microbiota-modulated diurnal oscillation in epithelial cells via group 3 innate lymphoid cells, Stat3 and epithelial clock components, with accompanying changes in epithelial lipid absorption and export. Moreover, genetic ablation of Nfil3 attenuates high fat diet-induced obesity in mice. [0084] Seven hundred and forty-eight genes exhibited statistically significant differences in their expression in the colonic tissue of N-methylserotonin-treated versus untreated mice (FDR- adjusted p-value <0.05; Table S3C,D); they include Nr1d2, Per3, Per2, Arntl and Clock. In vitro studies have indicated that N-methylserotonin binds to various serotonin (5-hydroxytryptamine) G protein-coupled receptors, including 5-Htr7 and 5-Htr2A. RNA-Seq analysis of colon did not reveal any statistically significant effects of N-methylserotonin administration on colonic expression of its known (Htr7, Htr2A) or related (Htr3, Htr4, Htr5 and Htr6) receptors. [0085] Glutamate levels were significantly higher in colonic tissue harvested from germ- free mice receiving 50 mg/kg/day of N-methylserotonin compared to untreated controls (21 ± 1.4 versus 11 ± 0.9 ng/mg tissue, respectively; p<0.01, unpaired t-test). Glutamate is known to degrade Arntl when directly applied to tissue slices. Knockout of the Per3 homolog Per2 reduces expression of the glutamate transporter (Eaatl, Slc1A3) and uptake of glutamate in the brain. These observations raise the possibility that one way that N-methylserotonin might influence colonic circadian regulators is through its effects on glutamate levels in this tissue. [0086] Circadian rhythm-related genes are known to be expressed in the myenteric plexus which coordinates colonic motility. Orally administered carmine red was used to determine the gastrointestinal transit time on day 17 of the 21-day experiment in germ-free mice whose drinking water was supplemented with 1 mg/kg/day or with 50 mg/kg/day of N-methylserotonin. The assay revealed that both doses of N-methylserotonin produced equivalent reductions in transit time (i.e., increased motility) compared to the untreated control group (p<0.0001, one-way ANOVA; FIG. 2H). [0087] Bacterial strains capable of mining of N-methylserotonin from orange fiber in vitro. Given that detection of N-methylserotonin was dependent on colonization with the bacterial consortium and consumption of orange fiber, it was next investigated which community members were responsible for its appearance. Each of the 14 community members was grown in monoculture to stationary phase in TYG medium; 10 ⁵ cells of each organism were incubated in 10 mL of a 5 mg/mL suspension of orange fiber for 8, 24, 48, 72 and 168 hours. N- methylserotonin was quantified using targeted LC-QqQ-MS. N-methylserotonin rose from levels that were not significantly above background at the 8h time point (background determined by measurements of control incubations containing sterile TYG medium), to levels that reached a maximum at the 72-hour time point. At this time point, Bacteroides ovatus strain TSDC 17.2 and a strain of Parabacteroides distasonis yielded similar quantities of product (29 ± 1 and 24 ± 2 ng N-methylserotonin/10 ⁶ cells, respectively). In contrast, the 12 other strains yielded <1.5 ng/10 ⁶ cells - an amount that was not appreciably higher than background levels (triplicate incubations/organism; FIG. 1C). Cultures grown in Wilkins-Chalgren anaerobe broth yielded results that were similar to those obtained with TYG medium (Table S4A), while testing each of these 14 organisms in an another nutrient rich medium (Mega medium 2.0) resulted in N- methylserotonin levels ranging from 5-25 ng/10 ⁶ cells for P. distasonis, Bacteroidesfinegoldii and Collinsella aerofaciens (Table S4A). Given its capacity to support the growth of a number of cultured anaerobic gut bacterial taxa, 24 other phylogenetically diverse human gut bacterial strains were screened in Wilkins-Chalgren anaerobe broth containing 5 mg/mL of orange fiber; none yielded amounts of N-methylserotonin significantly above background (< 0.5 ng/10 ⁶ cells) (Table S4B). [0088] Several other experiments were performed to characterize in vitro N- methylserotonin liberation by members of the 14 strain consortia. Adding either (i) 10 ⁸ heat-killed cells of either B. ovatus TSDC 17.2 or the P. distasonis strain that had been grown to stationary- phase in TYG, or (ii) lysates prepared by bead-beating of 10 ⁸ cells harvested from monocultures of each organism in TYG, or (iii) conditioned medium harvested from stationary phase TYG monocultures of each organism, to fresh TYG with orange fiber for 72 hours failed to yield levels of N-methylserotonin above background (Table S4C). These experiments indicate that mining requires intact viable cells. When N-methylserotonin was added at a concentration of 5 ng/mL to monocultures of the 14 strains that had been grown to stationary phase in TYG medium without orange fiber, no appreciable degradation was observed over a 72-hour period (3 replicate assays/organism/experiment; 97 ± 2% of input N-methylserotonin remaining intact/unmodified; triplicate incubations/condition; Table S4D). Evidence that B. ovatus TSDC 17.2 was not capable of synthesizing N-methylserotonin was also obtained. A homology-based search of the bacterial genome failed to reveal gene candidates involved in serotonin biosynthesis and metabolism. Moreover, when the organism was cultured in TYG medium supplemented with either tryptophan, tryptamine, serotonin, dimethylserotonin, trimethylserotonin, methyltryptamine, or S-adenosyl methionine (see Methods), N-methylserotonin was not detected above background after either 24 or 72 hours. Incubating this strain in TYG medium supplemented with either pea fiber, or two other commercial dietary fiber preparations (apple pectin or oat beta glucan) also did not yield levels of N-methylserotonin above background. [0089] Based on these in vitro findings, adult C57BL/6J germ-free mice were colonized with (i) a 4-member consortium comprised of the B. ovatus, P. distasonis, B. finegoldii and C. aerofaciens strains with in vitro mining activity, or (ii) the full 14-member consortium, or (iii) the 10 remaining strains from the 14-member consortium. Three days after gavage, animals (n=5/group) were switched from the unsupplemented HiSF-LoFV diet to a HiSF-LoFV diet supplemented with 10% (w/w) orange fiber. This diet was then administered ad libitum for 21 days (FIG. 3A,B). Short-read shotgun sequencing of DNA isolated from fecal samples collected at the time of euthanasia revealed that all strains in each consortium were able to colonize recipient animals (see Table S5 for their absolute abundances). The total biomass (bacterial genome equivalents/g feces) in mice harboring the 4-member consortium was 2-fold lower than in animals colonized with the 14-member consortium (p<0.01; one-way ANOVA) while there was no significant difference in bacterial load between animals hosting the 10- and 14-member communities (p=0.81, FIG. 3C). Targeted LC-QqQ-MS analysis of fecal samples obtained at the time of euthanasia revealed that levels of N-methylserotonin in mice colonized with the 4-strain consortium were equivalent to those in animals harboring the full 14-member community and significantly higher than in mice colonized with the 10-member consortium (p=0.002; one-way ANOVA; FIG. 3D). Animals colonized with the 4-member consortium had a significantly lower epididymal fat pad mass compared to mice colonized with the 10-member consortium (p=0.007 and p=0.001, respectively; one-way ANOVA). No significant differences in adiposity were noted between mice harboring the 4- and 14-member communities (FIG. 3E,F). Mice colonized with the 4-member consortium also had a statistically significant reduction in gut transit time compared to animals containing the 10-member community [184 ± 32 minutes (mean ± SD) versus 319±8 minutes, respectively; p<0.0001, one-way ANOVA). The 14-member community was associated with transit times (278 ± 14 minutes), that were also significantly shorter compared to mice with the 10-member community (p=0.025) yet were still significantly longer compared to mice harboring the 4-member community (p<0.0001) (FIG. 3G). [0090] Identifying genes involved in release of N-methylserotonin from orange fiber. Reasoning that microbial disruption of complex polysaccharides in fibers might be needed to liberate sequestered N-methylserotonin, a set of experiments was performed where 50 mg of orange fiber was incubated separately with 13 commercially available glycoside hydrolase preparations (see Methods). The greatest amount of N-methylserotonin was recovered when orange fiber was incubated with a preparation containing endoglucanases and cellulases from Trichoderma reesei (total yield; 2728 ± 26 ng/50 mg orange fiber) (Table S4E). When orange fiber (50 mg) was subjected to repeated rounds of extraction with methanol, small quantities of N-methylserotonin were released after each round (31 ng after two rounds; 171 ng in total after 15 rounds; Table S4F). Similar yields were obtained in separate experiments using acetonitrile or acetone (30-31 ng after two rounds of extraction). A comparison of the results of serial methanol extractions of N-methylserotonin against a spike-in compound added to orange fiber whose structure was similar to N-methylserotonin (2-methylserotonin) showed that 95% of 2- methylserotonin was removed by the first cycle of extraction and all of the remaining by the third cycle (Table S4F). These latter observations additionally supported the discovery that N- methylserotonin is "trapped" within orange fiber. [0091] A comparative genomic and functional genomics approach was taken to further characterize the mechanisms underlying release of N-methylserotonin from orange fiber. The N- methylserotonin `mining' activity of B. ovatus TSDC 17.2 was first compared to 11 other human gut-derived strains of B. ovatus. All strains were grown on TYG medium and subjected to the same protocol for assaying N-methylserotonin release from orange fiber as described herein (i.e., 10 <sup>5</sup> input bacterial cells/incubation containing 5mg/mL orange fiber; 72-hour incubation; 3 replicate assays/strain). Compared to control incubations lacking orange fiber where the yield of N-methylserotonin was 1.5 ± 0.2 ng/10 <sup>6</sup> cells (mean ± SD), it was found that all strains were able to release this compound. The amounts released varied between strains, however all strains had mining activities that were significantly lower than TSDC 17.2 (triplicate assays/strain; one-way ANOVA, all P-values <0.0001). B. ovatus 115 had the lowest activity [2.8 ± 0.1 ng (mean ± SD) N-methylserotonin released/10 <sup>6</sup> cells compared to 33.3 ± 2.8 ng/10 <sup>6</sup> cells for TSDC 17.2 (FIG. 4A, Table S4G)]. [0092] As noted herein, several of the bacterial taxa tested exhibited mining activity that was dependent upon the growth medium used. This observation led to a search for components in TYG whose presence was essential for N-methylserotonin release. This search yielded hemin, a known regulator of gene expression in Bacteroides species. While all strains grew to comparable densities in TYG with or without hemin, no microbe-dependent N-methylserotonin release occurred when these cells were added to reactions containing fresh hemin-deficient TYG plus orange fiber (controls; incubations containing TYG ± hemin but lacking orange fiber; FIG. 4B, Table S4H). [0093] To identify the genes likely to contribute to N-methylserotonin release, the genomes of all 12 strains were sequenced, annotated all of their known or predicted encoded proteins, and performed microbial RNA-Seq analysis of gene expression in B. ovatus TSDC 17.2 and B. ovatus 115 grown under conditions identical to those used during assays for N- methylserotonin release activity (72-hour incubation with or without orange fiber in TYG medium with or without hemin, or in MEGA medium). Gene expression in strain TSDC 17.2 under the permissive N-methylserotonin releasing condition (TYG medium ± orange fiber) was first compared with gene expression under non-permissive conditions (TYG minus hemin with and without orange fiber).133 genes were identified that (i) exhibited a statistically significant >1 log2-fold increase in expression under releasing conditions (Benjamini and Hochberg FDR- adjusted Wald test p-value <0.05), and (ii) were either not significantly differentially expressed (FDR-adjusted p-value > 0.1), or were significantly downregulated (FDR-adjusted p-value <0.05) under non-releasing conditions (see Table S6A for a list of these 133 genes plus FIG. 4C). [0094] Natural products are embedded/entrapped in dietary fiber through various chemical and physical interactions. As noted herein, the orange fiber preparation contained nearly 60% (w/w) uronic acid, with prominent representation of homogalacturonan, rhamnogalacturonan, xylan and arabinan structures (Table S1B). Bacteroides species possess multiple polysaccharide utilization loci (PULs). These PULs encode proteins (SusC and SusD homologs) involved in binding and import of various glycan structures as well as carbohydrate active enzymes (CAZymes) that catalyze their degradation [glycoside hydrolases (GH) and polysaccharide lyases (PL)]. Therefore, previously described methods were used to identify PULs and CAZyme gene clusters present in Bacteroides ovatus strains TSDC 17.2 and 115. The results revealed that PUL conservation and synteny between the two strains is very high (Table S7). [0095] Among the 133 genes with statistically significant differential expression in TSDC 17.2, those that manifested the most prominent induction under N-methylserotonin releasing conditions were concentrated in PUL27, PUL28 and PUL29, and to a lesser extent in several other PULs (e.g., PUL4 and PUL13). Proteins encoded by these PULs exhibit >95% amino acid sequence identity with those in strain 115 and share orthologs in the other strains tested (Table S6A, Table S7). Functional assignments for these proteins were made by identifying their best scoring alignments with the sequences of experimentally characterized CAZymes in the CAZy database (www.cazy.org) (Table S6B). The results disclosed members of CAZyme families with reported activities against the backbones of homogalacturonan [GH family 105 (unsaturated rhamnogalacturonyl hydrolase/unsaturated glucuronyl hydrolase)] or rhamnogalacturonan [PL9, PL11 (rhamnogalacturonan lyase); GH28 (RGI-specific a-galacturonidase)]. These structures are prominently represented in pectin and in the orange fiber preparation of the present disclosure (>50% of glycosyl linkages, Table S1B). The PULs also included CAZymes with predicted activities directed at oligosaccharides linked to these backbone structures [arabinofuranosidase (GH4318), galactosidase (GH36), and apiosidase (GH140)]. [0096] Despite the high degree of PUL conservation between B. ovatus TSDC 17.2 and B. ovatus 115, almost none of their component genes are expressed in the latter strain under mining-permissive conditions (Table S7). In an attempt to define the origin of the observed differences in expression of these PUL genes, and by extrapolation, the discordant N- methylserotonin mining activities of strains TSDC 17.2 and 115, potential transcriptional regulons were reconstructed using comparative genomics (FIG. 7). PUL27, PUL28 and PUL29 form a large chromosomal cluster of 60-70 genes that encode 28 CAZymes, six SusC/SusD transport systems, and three paralogs of a previously characterized rhamnogalacturonan-specific regulator in Bacteroides thetaiotaomicron, HTCS_Rgu-2. Hybrid two-component systems (HTCS) are single polypeptide chains comprised of a transmembrane sensor histidine kinase, a DNA-binding response regulator, and a carbohydrate sensing domain. The reconstructed HTCS_Rgu-2 regulon in B. ovatus strains includes 42 genes from PUL27, PUL28, PUL29, and PUL30, of which 30 were significantly upregulated (FDR-adjusted p-value < 0.05) in the presence of orange fiber (Table S7). However, all identified HTCS_Rgu-2 binding sites are highly conserved between the 17.2 and 115 strains, and the orthologous pairs of HTCS regulators are 98¬99% identical to each other, indicating (i) conservation of this feature of regulation of rhamnogalacturonan-I utilization loci between the two strains of B. ovatus and (ii) that the observed difference in regulon expression is likely not ascribable to this HTCS alone. [0097] N-methylserotonin levels and microbiome CAZyme gene abundances in humans consuming fiber snack prototypes. To assess the translatability of results obtained from these in vitro analyses and mouse model to humans, two exploratory 10-week open-label, single group assignment studies were performed. The studies involved orange fiber- and pea fiber- supplemented snack food prototypes and dizygotic twins 36.6 ± 2.9 years old (mean ± SD) recruited from the Missouri Adolescent Female Twin Study (MOAFTS) cohort. The two studies had the same design (see Methods), with participants supplementing their normal, unrestricted diets with one or the other snack food prototype. In brief, consumption of the fiber snack prototypes escalated from none consumed during the first two weeks, to one snack per day during the third week, then two servings a day during week 4, and finally, beginning week 5, three snacks at which time the maximum daily dose of —25-30g per day of either pea fiber (Study 1; n=18 participants) or orange fiber (Study 2; n=24 participants, including all 18 from Study 1) was achieved. This dose level was then maintained for 4 weeks (see Table S8A for the composition of the snack prototypes and Table S8B for participant characteristics). Importantly, the orange and pea fiber preparations used for these human studies were obtained from the same commercial sources as those used in preclinical studies. Therefore, analysis of fecal samples collected during the course of these two studies, including from subjects who had participated in both, provided an opportunity to examine the relationship between features of the microbiome and fecal levels of N-methylserotonin as a function of fiber consumption. Specifically, the present disclosure enabled an assessment of whether mining was robust to different background diets, exhibited specificity for orange fiber and was dependent upon the amount of orange fiber consumed. [0098] N-methylserotonin it was present in 98% of the 48 samples obtained from participants consuming the orange fiber snack prototype (FIG. 5A and Table S8B). Fecal N- methylserotonin levels were significantly correlated with the number of orange fiber snacks consumed per day (Pearson's r=0.72; p<0.0001) with concentrations reaching 72.5 ± 38.4 µM (mean ± SD) at maximal dose. To put this concentration in context, the reported IC50 of binding to a known N-methylserotonin receptor, 5-HT1A, is —2nM. Fecal serotonin levels were 0-8.6% of that of N-methylserotonin (7±5.7 µM; mean + SD) and did not vary significantly as a function of the dose of orange fiber (Pearson's r = ¬0.105, p=0.381; one-way ANOVA p=0.62) (Table S8B). In contrast, N-methylserotonin was undetectable (<0.05 µg/g) in 87% of the 36 fecal samples collected from individuals consuming the pea fiber snack prototype during the supplementation period (at week 3 when one snack per day was being consumed, and at end of week 5, when the maximum dose was being administered) (see the legend to Table S8B regarding the four donors who had positive samples). [0099] Neither the relative abundance of B. ovatus nor of any of the bacterial taxa (Amplicon Sequence Variants, ASVs) that exhibited statistically significant changes in their relative abundances in the fecal microbiota after orange fiber and/or pea fiber snack consumption (Table S8C) had statistically significantly correlations with N-methylserotonin levels at the end of week 5 (Spearman correlation q>0.30) [A statistically significant loge-fold change in relative abundance of a taxon at week 5 compared to the pre-intervention period was defined by q-value <0.1 (linear mixed effect model) and, using higher order singular value decomposition, by positioning of that taxon at the tails (a<0.1) of the distribution of ASVs along tensor component 1; see Methods]. [0100] Using shotgun sequencing datasets generated from fecal DNA samples collected at the end of weeks 1 and 5 of the study, a Spearman correlation was performed between (i) the abundances of 213 annotated CAZyme genes [glycoside hydrolases (GH) and polysaccharide lyases (PL)] that were present in at least one study participant at these time points, and (ii) fecal levels of N-methylserotonin prior to fiber supplementation and at the end of week 5 (Table S8D). CAZyme genes whose loge fold-changes in abundance were significantly correlated with levels of N-methylserotonin (q-value <0.1) are shown in FIG. 5B. The strongest positive correlation was with PL9 (rhamnogalacturonan lyase; Spearman rho = 0.51, q-value = 0.025) (FIG. 5B, Table S8E) — a CAZyme whose expression was significantly upregulated in vitro under mining permissive conditions (loge-fold change 1.2, FDR adjusted p-value (q) = 2.2 x104, FIG. 4C, Table S6A and Table S7). The CAZyme gene with the second most positive correlation with levels of N-methylserotonin was GH5 37 (Spearman rho=0.438, q=0.08) which has reported specificity for f3-glucan/cellulose. It is notable that in vitro enzymatic digestion experiments of the present disclosure revealed that a preparation enriched in endoglucanases and cellulases exhibited a high level of N-methylserotonin mining activity (Table S4E). Other CAZymes significantly correlated with fecal N-methylserotonin levels included GH30 5 (Spearman rho=0.44, q=0.08) and GH59 (Spearman rho=0.52, q=0.02) which possess homogalacturonan/rhamnogalacturonan processing functions or target pectin components such as galactans and arabinogalactans (FIG. 5B). As was the case with PL9, and GH5 37, the abundances of GH30 5 and GH59 increased significantly in the microbiomes of participants consuming the orange fiber snack (analogous to ASVs, a statistically significant loge-fold change for a CAZyme gene was defined by q-value < 0.1 (linear mixed-effects model) and, using higher order singular value decomposition, by the its positioning at the tails (a<0.1) of the distribution of CAZyme genes along tensor component 1). Taken together, the results of the human study of the present disclosure revealed an orange fiber specific, dose-dependent accumulation of N- methylserotonin in feces, where its concentration was positively correlated with the abundances of microbiome genes encoding CAZymes targeting pectic glycans. [0101] Screening of plant sources for N-methylserotonin. Seeking to identify whether the presence of N-methylserotonin is indeed ubiquitous in citrus plants, an array of 23 additional commercially available sources of citrus fibers , sourced from major citrus producing countries across the globe, was screened (Table S9). An orange fiber preparation from Fiberstar, served as control. All but two of the samples tested had significant quantities of N-methylserotonin upon enzymatic digestion, with the ones lacking being either a highly purified/processed pectin product or else a heavily processed unknown citrus fiber blend. The amount of N-methylserotonin present was highly variable between both sample type as well as between individual samples, with some samples being highly variable but approaching control levels (e.g. grounded orange peel, 67±21%) while others having low but more consistent levels (e.g. grounded lemon peel, 3±0.3%). Of particular note is that consistent with the observation of N-methylserotonin being entrapped within orange fiber, the “fine” preparation of the orange fiber used herein (i.e., more heavily refined & processed) yielded much less N-methylserotonin than its less processed counterpart (15±8%). [0102] To further confirm these results, a follow-up screen consisting of locally sourced citrus products were carried out (Table S10). As the orange fiber used herein was described by the manufacturers to be sourced from citrus juice processing, an attempt was made to delineate plausible components of citrus juice processing in the screen. Commonly found edible table orange, lemon, lime, and grapefruits were divided into components labeled “Skin,” “Fruit (with pulp),” “Pulp,” and “Juice” prior to being applied to the same enzymatic screen as described above (Table S10). N-methylserotonin was not found in grapefruit and found in low quantities in the lemon and lime. As expected, it is prominently found in the skin of orange fruits, followed by the fruit, pulp, and juice (161±65%, 122±52%, 35±4%, 36±1%; all relative to the orange fiber used herein). Entrapment of N-methylserotonin is further confirmed by the observation that relative to the enzymatic digestion, very low quantities of N-methylserotonin was released from the same orange peel using non-enzymatic processing methods such as mechanical disruption, methanol extraction, or liquid nitrogen freeze-thawing (Table S10). The presence of N- methylserotonin in the juice is likely due to residue fibrous components remaining in the orange juice during processing, where filtration of orange juice prior to the enzymatic assay is shown to reduce N-methylserotonin levels to negligible levels. [0103] Having confirmed the specificity of N-methylserotonin within citrus fruits and its abundance in oranges, the scope of the screen was broadened to confirm the specificity of plants containing N-methylserotonin. The same enzymatic digestion assay was applied to a broad range of various fruit, vegetable, and grain samples, in total reporting results from 133 different types of edible plants in Table S11(A-E). Samples selected included major global staples such as corn, wheat, rice, and cassava as reported by the Food and Agriculture Organization of the United Nations, as well as commonly consumed fruits and vegetables in America as reported by the USDA and FDA. N-methylserotonin was found in only three sample types, all of which are “peppers” in the Zanthoxylum genus which are in the Rutaceae family alongside citrus fruits. These include two types of the Japanese mountain pepper (Z. piperitum), which is reported to contain N-methylserotonin, and one preparation of the Chinese Sichuan pepper (Z. bungeanum). The otherwise evident absence of N-methylserotonin, including samples belonging to members of the Solanaceae family (various types of hot chili peppers as well as bell peppers) and the Piperaceae family (common black pepper) indicate that this compound is indeed specific to citrus fruits and other members in the Rutaceae family. [0104] DISCUSSION [0105] Gnotobiotic mice colonized with defined collections of human gut microbes were used together with in vitro assays to show that N-methylserotonin is a compound present in orange fiber that is directly released only by specific members of the gut community to produce significant effects on host physiology and metabolism. A short duration study of a small cohort of adult dizygotic twins disclosed dose-dependent, orange-fiber specific accumulation of N- methylserotonin in their feces. As described herein, orange fiber preparations and their releasable N-methylserotonin are naturally-based analogs of polysaccharide-based drug delivery systems. [0106] Many natural products are embedded in dietary fiber through various chemical and physical interactions, including hydrophobic interactions, hydrogen as well as covalent bonds, and/or physical entrapment. The term "celobiotic" (from the latin `conceal or disguise') is proposed herein to describe a bioactive compound that is liberated from fibers, rather than synthesized or further metabolized, through the actions of one or more microbial enzymes, and whose biological/pharmacologic activities are not dependent upon additional microbial biotransformation. [0107] Several key results aided in deciphering how N-methylserotonin is liberated from orange fiber. A switch was discovered for turning mining activity on and off: Bacteroides ovatus TSDC 17.2, a prominent miner in the preclinical gnotobiotic mouse model described herein, exhibited hemin-dependent release of N-methylserotonin in vitro. Pronounced B. ovatus strain- specific differences in N-methylserotonin releasing activities were documented under in vitro mining permissive conditions; hemin-dependence was a feature of release in all strains. Taking advantage of this hemin-dependency and strain-specificity, microbial RNA-Seq analysis of gene expression in a strong versus weak B. ovatus mining strain incubated in the presence or absence of orange fiber and presence or absence of hemin, revealed a set of glycoside hydrolase and polysaccharide lyase genes associated with release; their known/predicted substrate specificities were consistent with prominent representation of pectic polysaccharides present in orange fiber. Moreover, these in vitro results translated to humans, where treatment with orange and pea fiber snack prototypes disclosed orange fiber-specific accumulation of N-methylserotonin in their feces, with levels of this compound correlating most significantly with the abundances of PL and GH genes involved in processing of glycan structures in pectins. In this respect, and although the specific means of small molecule entrapment differ, it is noteworthy that several members of Bacteroidetes have recently been shown to possess a polysaccharide utilization locus that encodes esterases capable of extracting ferulic acid, a well-documented component of multiple cereal grains. [0108] There have been a limited number of reports describing the biological effects of N-methylserotonin; most of these studies have been conducted in vitro. Similar to serotonin, N- methylserotonin is able to increase glucose uptake in cultured rat muscle via its agonist activity on the 5-HT2A receptor. A maleated form of methylserotonin enhanced insulin secretion in human and mouse beta cells via activation of the 5-HT2B receptor. The closely related compound alpha-methylserotonin, by means of its engagement of 5-HT1 and 5-HT2A, is able to increase glycogen synthesis in rat hepatocytes via a direct increase in glycogen synthase activity as well as cAMP-dependent inactivation of glycogen phosphorylase; binding of serotonin to 5-HT2B/C receptors has an opposing effect and decreases glycogen synthesis. [0109] It was found that oral administration of N-methylserotonin to germ-free mice consuming a high saturated fat, low fiber representative USA diet produced a number of phenotypic changes including reduced adiposity and alterations in hepatic energy (glucose) metabolism. Intriguingly, N-methylserotonin affected expression of regulators of circadian rhythm in both liver and colon, including Arntl, Clock, Pert, Per3, plus Nfil3 and its repressor, Nr1d2. Gut microbiota has been linked to microbiota-regulated diurnal oscillation of epithelial expression of clock components, and the effects of these components (e.g., Nfil3) on lipid absorption and export. RNA-Seq did not reveal significant effects of N-methylserotonin on intestinal or liver levels of mRNAs encoding its known (Htr7, Htr2A) or related (Htr3, Htr4, Htr5 and Htr6) receptors. However, the absence of changes in receptor expression does not preclude effects on their signal transduction pathways, or the possibility that N-methylserotonin exerts its effects on circadian regulators through other metabolites, such as glutamate, whose colonic levels increased after N-methylserotonin administration to germ-free animals. [0110] The ability to manipulate luminal levels of N-methylserotonin in gnotobiotic mice fed orange fiber by including or excluding N-methylserotonin-releasing bacterial species in their gut community illustrates a synbiotic design strategy where fibers containing concealed celobiotics are administered together with probiotic `miners' to enhance/expand the biological effects of fibers to the benefit of the host. For example, administration of free, unbound N- methylserotonin to germ-free mice was found to produce a dose-dependent increase in gastrointestinal transit time, indicating that a synbiotic composed of orange fiber plus a N- methylserotonin miner such as B. ovatus represents an approach for treatment of certain forms of irritable bowel syndrome (IBS-C). Moreover, the systemic effects observed on metabolism in mice exposed to N-methylserotonin indicate the potential for additional beneficial pharmacological properties. [0111] As disclosed herein, celobiotics provide valuable analytic opportunities to both food and microbiome scientists, as well as for synbiotic compositions and therapeutic methods. Liberation of celobiotics from fiber preparations during in vitro incubations of intact uncultured (fecal) microbiota samples, defined consortia of cultured microbes, or single microbial strains operationally define the compositional `equivalence' of different lots of a fiber preparation and/or a comparative assessment of the impact of different food processing methods. As disclosed herein, knowledge of whether a consumer of a fiber preparation harbors a gut microbiota with miners of a specific celobiotic enables analysis of interpersonal variations in responses to that fiber in longer duration clinical studies. A corollary is that more personalized dietary recommendations are enabled by the present disclosure about the types of fiber preparations providing specific health benefits based on a given consumer's known microbiota/microbiome composition. [0112] SUPPLEMENTAL TABLES [0113] Table S1(A-B) — Chemical analysis of fiber preparations; related to FIG. 1(A- C), FIG. 2(A-H), and FIG. 5(A-B). Table S1A Composition of orange and pea fibers. Table S1B Linkage analysis of orange fiber. [0114] Table S2(A-B) — Cecal analytes/features identified by LC-Qtof-MS; related to FIG. 1(A-C). Table S2A Features that are colonization and fiber-dependent; Table S2B Other features. All features shown have peak areas ≥ 3-fold higher in colonized mice consuming the HiSF-LoFV + orange fiber diet relative to the other groups. Features are organized by M/Z. Data are presented as peak area. [0115] Table S3(A-D) — Differentially expressed genes in the livers and colons of germ- free mice treated with 50mg/kg/d N-methylserotonin compared to untreated germ-free controls; related to FIG. 2(A-H). Table S3A Upregulated genes in liver. Table S3B Downregulated genes in liver. Table S3C Upregulated genes in colon. Table S3D Downregulated genes in colon. [0116] Table S4(A-H) — In vitro screening of bacterial strains for N-methylserotonin releasing activity; related to FIG. 1(A-C) and FIG. 4(A-C). Table S4A Levels of N- methylserotonin (ng) released by cultured bacterial strains in TYG with and without hemin, Wilkins-Chalgren anaerobe broth or MEGA medium 2.0 containing orange fiber. Table S4B Screening of additional bacterial strains for N-methylserotonin release from orange fiber. Table S4C Additional control experiments of microbial N-methylserotonin release. Table S4D N- methylserotonin degradation test. Table S4E Release of N-methylserotonin from orange fiber via enzymatic reaction after 72 hours. Table S4F Recovery of N-methylserotonin from orange fiber after repeated rounds of methanol extraction, compared to recovery of a closely related spike-in compound (2-methylserotonin) under the same conditions. Table S4G Screening of additional Bacteroides ovatus strains for N-methylserotonin release from orange fiber using TYG medium with hemin. Table S4H Screening of additional Bacteroides ovatus strains for N-methylserotonin release from orange fiber using TYG medium without hemin. N-methylserotonin levels are shown at the time point specified, tested using a concentration of 5 mg/ml orange fiber, normalized to 10 ⁶ microbes where applicable, and n = 3. ND (not detected) = N-methylserotonin levels below 0.02 ng. [0117] Table S5 - Absolute abundances of fecal bacterial community members measured at experimental day 21 (mean ± SD); related to FIG. 3(A-G). [0118] Table S6(A-B) - List of "mining" (N-methylserotonin releasing) candidate genes in B. ovatus TSDC 17.2, related to FIG. 4(A-C). Table S6A B. ovatus TSDC 17.2 genes, arranged by log2fold-change under the permissive releasing condition (TYG medium containing hemin, with versus without orange fiber). Genes shown exhibit >1 log2-fold increased expression under the permissive condition, but are not significantly upregulated or downregulated under non- releasing conditions. Highlighted in blue are statistically significant decreases in expression of the same gene under conditions where there is no N-methylserotonin release. Table S6B Functional predictions of CAZymes deemed to be candidate mediators of N-methylserotonin release. [0119] Table S7(A-B) —PUL map of B. ovatus TSDC 17.2; related to FIG. 4(A-C). B. ovatus TSDC 17.2 genes designated as candidates for involvement in N-methylserotonin release from orange fiber (OF) are highlighted in bold font. Table S7A B. ovatus TSDC 17.2; Table S7B Corresponding PUL (if present) in B. ovatus 115. B. ovatus TSDC 17.2 genes designated as candidates for involvement in N-methylserotonin release from orange fiber (OF) are highlighted in bold font and x = present. [0120] Table S8(A-E) — Levels of N-methylserotonin and serotonin in feces collected from adult dizygotic twins consuming orange fiber- or pea fiber-containing snack food prototypes; related to FIG. 5(A-B). Table S8A Composition of the snack food prototypes. Table S8B Ages and BMIs of participants plus levels of N-methylserotonin and serotonin in their fecal samples collected at the end of study weeks 1, 3 and 5. Table S8C ASVs with statistically significant loge-fold changes in relative abundances in the fecal microbiota of participants between the pre-intervention and 5-week time points of the pea and orange fiber snack studies. Table S8D-Week 1 and Table S8D-Week 5 CAZyme (GH and PL) gene representation in the fecal microbiomes of participants consuming orange fiber snacks. Table S8E Spearman correlations of abundances of GH and PL genes and levels of N-methylserotonin in fecal samples collected from study participants at week 5.

[0121] Table S9. Assessment of commercially available orange fibers for the presence of N-methylserotonin. [0122] Table S10. Assessment of locally commercially available citrus fruits for the presence of N-methylserotonin. [0123] Table S11(A-E) — N-Methylserotonin screening in other plants, relative to orange fiber (OF). Samples containing N-methylserotonin, where applicable, are mean±SD; "-" indicate not found. Table S11A cash crops and staples. Table S11B common prebiotic supplements. Table S11C spices. Table S11D fruits. Table S11E vegetables. Table S1A. Composition of orange and pea fibers.

Table S2A. Features that are colonization and fiber-dependent. Features that are colonization and fiber-dependent Colonized M/ 191.1 nin 362.1 372. 385.0 416. 416. 427.0 452. 459.2 462. 466.1 473.2 561.3 633.3

408.2423 10.38 64731 7437 8812 413.1975 10.39 132575 18385 30995 4143342 87 90818 0 16476 416 416 416 416 416 416 418 424 424 428 430 430 432 433 434 434 435 436 442 444 448 451 454 454 468 468 471 478 479 496 497 503 507 507 515 522 533 533 539 545 547 547 547 549 579 619 653.1755 6.57 54859 14085 0 1079.6506 6.29 36667 9593 12101 Table S3A. Upregulated genes in liver. 11 33 31 27 62 18 69 53 67 76 23 10 76 10 67 14 27 66 18 15 24 64 67 13 66 70 54 72 74 22 13 10 10 66 26 23 24 59 75 13 66 50 22 23 67 22 20

211389 Suox sulfite oxidase -0.27 4.53E-02 1 2 2 1 1 1

Table S3C. Upregulated genes in colon. G 3 3 2 4 3 1 2 2 4 2 2 2 2 2 6 6 2 2 3 3 2 7 1 2 1 3 2 2 3 2 9 1 1 2 5 3 1 2 1 1 4 3 1 2 3 1 5 2 2 2 7 6 5 1 2 1 1 5 2 2 1 1 1 1 2 6 2 6 6 1 1 1 1

Table S3D. Downregulated genes in colon. G 10 10 1

T B B B B

Table S4D. N-methylserotonin degradation test. Ending N-methylserotonin level Bacterial strain Starting N-methylserotonin level after 72h incubation (ng) B

Table en en endo

Table S4G. Screening of additional Bacteroides ovatus strains for N-methylserotonin release from orange fiber using TYG media with hemin. B B

Table S4H. Screening of additional Bacteroides ovatus strains for N-methylserotonin release from orange fiber using TYG media without hemin.

[0124] Definitions and methods described herein are provided to better define the present disclosure and to guide those of ordinary skill in the art in the practice of the present disclosure. Unless otherwise noted, terms are to be understood according to conventional usage by those of ordinary skill in the relevant art. [0125] In some embodiments, numbers expressing quantities of ingredients, properties such as molecular weight, reaction conditions, and so forth, used to describe and claim certain embodiments of the present disclosure are to be understood as being modified in some instances by the term “about.” In some embodiments, the term “about” is used to indicate that a value includes the standard deviation of the mean for the device or method being employed to determine the value. In some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters are be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the present disclosure are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The numerical values presented in some embodiments of the present disclosure may contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements. The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. [0126] In some embodiments, the terms “a” and “an” and “the” and similar references used in the context of describing a particular embodiment (especially in the context of certain of the following claims) are construed to cover both the singular and the plural, unless specifically noted otherwise. In some embodiments, the term “or” as used herein, including the claims, is used to mean “and/or” unless explicitly indicated to refer to alternatives only or to refer to the alternatives that are mutually exclusive. 193 [0127] The terms “comprise,” “have” and “include” are open-ended linking verbs. Any forms or tenses of one or more of these verbs, such as “comprises,” “comprising,” “has,” “having,” “includes” and “including,” are also open-ended. For example, any method that “comprises,” “has” or “includes” one or more steps is not limited to possessing only those one or more steps and may also cover other unlisted steps. Similarly, any composition or device that “comprises,” “has” or “includes” one or more features is not limited to possessing only those one or more features and may cover other unlisted features. [0128] All methods described herein are performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the present disclosure and does not pose a limitation on the scope of the present disclosure otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the present disclosure. [0129] Groupings of alternative elements or embodiments of the present disclosure disclosed herein are not to be construed as limitations. Each group member is referred to and claimed individually or in any combination with other members of the group or other elements found herein. One or more members of a group are included in, or deleted from, a group for reasons of convenience or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims. [0130] To facilitate the understanding of the embodiments described herein, a number of terms are defined herein. The terms defined herein have meanings as commonly understood by a person of ordinary skill in the areas relevant to the present disclosure. Terms such as "a," "an," and "the" are not intended to refer to only a singular entity, but rather include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the disclosure, but their usage does not delimit the disclosure, except as outlined in the claims. 194 [0131] All of the compositions and/or methods disclosed and claimed herein may be made and/or executed without undue experimentation in light of the present disclosure. While the compositions and methods of this disclosure have been described in terms of the embodiments included herein, it will be apparent to those of ordinary skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit, and scope of the disclosure. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope, and concept of the disclosure as defined by the appended claims. [0132] This written description uses examples to disclose the disclosure, including the best mode, and also to enable any person skilled in the art to practice the disclosure, including making and using any devices or systems and performing any incorporated methods. The patentable scope of the disclosure is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal language of the claims. 195